InvestSMART

Percheron Therapeutics Limited (ASX:PER)

ALERT: Price-sensitive ASX Announcement for PER
Current share price for PER : $0.004 -0.003 (-41.67%)+
Announcement
Release
16 Mar 2026 9:59AM
Price at Release
$0.006
Full Release
download
Summary
Percheron Therapeutics Limited has announced a non-renounceable entitlement offer to raise approximately $2.2 million, providing shareholders with the opportunity to purchase two new shares for every five existing shares at an issue price of $0.005 each. This offer represents a 20% discount to the company's recent trading average and includes a free attaching option for every two new shares, exercisable at $0.01 each with a two-year term. The capital raised will support the development of the company’s lead asset, HMBD-002, an antibody targeting VISTA for cancer treatment, and other operational expenses. The offer closes on April 8, 2026, and is not underwritten, managed by Blue Ocean Equities and Cygnet Capital.
Key Points
  • Non-renounceable entitlement offer to raise $2.2 million.
  • Two new shares for every five existing at $0.005 each.
  • Offer includes one free option per two shares, exercisable at $0.01.
  • Funds to develop HMBD-002, an antibody targeting VISTA.
  • Offer closes April 8, 2026, not underwritten.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.